論文　2020年

論文

論文　2020年

  • Fujioka A, Imanishi Y, Kobayashi I, Hirakawa T, Inoue A, Harada K, Taguchi M, Sugiura Y, Yamada H, Miyaoka D, Hayashi N, Emoto M, Inaba M. Effect of etelcalcetide on parathyroid hormone secretion by primary hyperparathyroidism patient-derived primary parathyroid cells. J Bone Miner Metab 2020 Oct 12.
  • Hayashi N, Imanishi Y, Hirakawa T, Kobayashi I, Tateishi T, Miyaoka D, Nagata Y, Mori K, Morioka T, Inoue A, Harada K, Inaba M, Emoto M. Etelcalcetide decreases the PTH–calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism. Journal of Bone and Mineral Metabolism 2020 Nov 16.
  • Inaba M, Kumeda Y, Yamada S, Toi N, Hamai C, Noguchi K, Yasuda E, Furumitsu Y, Emoto M, Ohno Y. Association of higher arterial ketone body ratio (acetoacetate/β-hydroxybutyrate) with relevant nutritional marker in hemodialysis patients. BMC Nephrol 2020;21:510.
  • Imanishi Y, Ito N, Rhee Y, Takeuchi Y, Soo Shin C, Takahashi Y, Onuma H, Kojima M, Kanematsu M, Kanda H, Seino Y, Fukumoto S. Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia. J Bone Miner Res 2021;36:262-270.
  • Kakutani Y, Morioka T, Mori K, Yamazaki Y, Ochi A, Kurajoh M, Fukumoto S, Shioi A, Shoji T, Inaba M, Emoto M. Albuminuria rather than glomerular filtration rate is associated with vascular endothelial function in patients with type 2 diabetes. J Diabetes Complications 2020;34:107702.
  • Kanazawa I, Inaba M, Inoue D, Uenishi K, Saito M, Shiraki M, Suzuki A, Takeuchi Y, Hagino H, Fujiwara S, Sugimoto T, from the Japan Osteoporosis Society Lifestyle diseases-related Fracture Risk Investigation C. Executive summary of clinical practice guide on fracture risk in lifestyle diseases. J Bone Miner Metab 2020;38:746-758.
  • Kurajoh M, Fukumoto S, Emoto M, Murase T, Nakamura T, Ishihara T, Go H, Yamamoto K, Nakatani S, Tsuda A, Yamada S, Morioka T, Mori K, Imanishi Y, Inaba M. Independent association of plasma xanthine oxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry. Clin Chem Lab Med 2020;58:780-786.
  • Kurajoh M, Inaba M, Motoyama K, Kuriyama N, Ozaki E, Koyama T, Yamada S, Morioka T, Imanishi Y, Emoto M. Inverse association of plasma leptin with cortical thickness at distal radius determined with a quantitative ultrasound device in patients with type 2 diabetes mellitus. J Diabetes Investig 2020;11:174-183.
  • Kurajoh M, Fukumoto S, Murase T, Nakamura T, Nagata Y, Nakatani S, Tsuda A, Yamada S, Morioka T, Mori K, Imanishi Y, Kawada N, Hirata K, Emoto M. Plasma xanthine oxidoreductase activity change over 12 months independently associated with change in serum uric acid level: MedCity21 health examination registry. Clin Chem Lab Med 2020;0563.
  • Kuriyama N, Ozaki E, Koyama T, Matsui D, Watanabe I, Tomida S, Nagamitsu R, Hashiguchi K, Inaba M, Yamada S, Horii M, Mizuno S, Yoneda Y, Kurokawa M, Kobayashi D, Fukuda S, Iwasa K, Watanabe Y, Uehara R. Evaluation of myostatin as a possible regulator and marker of skeletal muscle-cortical bone interaction in adults. J Bone Miner Metab 2020 Oct 12.
  • Maruo S, Motoyama K, Hirota T, Kakutani Y, Yamazaki Y, Morioka T, Mori K, Fukumoto S, Shioi A, Shoji T, Inaba M, Emoto M. Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes. Diabetol Int 2020;11:368-375.
  • Masaki H, Imanishi Y, Naka H, Nagata Y, Kurajoh M, Mori K, Emoto M, Miki T, Inaba M. Bazedoxifene improves renal function and increases renal phosphate excretion in patients with postmenopausal osteoporosis. J Bone Miner Metab 2020;38:405-411.
  • Miyaoka D, Imanishi Y, Kato E, Toi N, Nagata Y, Kurajoh M, Yamada S, Inaba M, Emoto M. Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism. Endocrine 2020;69:642-649.
  • Miyaoka D, Imanishi Y, Yano M, Toi N, Nagata Y, Kurajoh M, Yamada S, Morioka T, Emoto M. Effects of denosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremmision tumor-induced osteomalasia initially treated with conventional therapy: Case report. Bone Rep 2020;13:100736.
  • Miyashima M, Shoji T, Kakutani Y, Yamazaki Y, Ochi A, Morioka T, Shinohara-Mitsuki K, Fukumoto S, Shioi A, Inaba M, Emoto M. Inter-Arm Blood Pressure Difference in Diabetes Mellitus and Its Preferential Association with Peripheral Artery Disease. J Atheroscler Thromb 2020;27:780-788.
  • Morioka T. Myostatin: The Missing Link between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease? J Atheroscler Thromb 2020;27:1036-1038.
  • Nakatani S, Ishimura E, Machiba Y, Fujimoto K, Uedono H, Tsuda A, Mori K, Emoto M, Inaba M. Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease Patients. Case Rep Nephrol Dial 2020;10:9-17.
  • Nakatani S, Mori K, Okuno S, Nishide K, Morioka F, Machiba Y, Uedono H, Tsuda A, Ishimura E, Shoji S, Yamakawa T, Inaba M, Emoto M. Kidney Enlargement Suppression by Cinacalcet In ADPKD Patient with Hemodialysis: A Case Report. Arch Clin Med Case Rep 2020;4:671-679.
  • Nakatani S, Mori K, Sonoda M, Nishide K, Uedono H, Tsuda A, Emoto M, Shoji T. Association between Serum Zinc and Calcification Propensity (T50) in Patients with Type 2 Diabetes Mellitus and In Vitro Effect of Exogenous Zinc on T50. Biomedicines 2020;8:337.
  • Nishide K, Nakatani S, Mori K, Morioka F, Machiba Y, Uedono H, Tsuda A, Inaba M, Ishimura E, Emoto M. Clinical and Histopathological Features of Acute Kidney Injury in Adult Onset Minimal Change Nephrotic Syndrome. Clin Exp Nephrol 2020 Nov 28.
  • Sasaki K, Shoji T, Kabata D, Shintani A, Okute Y, Tsuchikura S, Shimomura N, Tujimoto Y, Nakatani S, Mori K, Shioi A, Inaba M, Emoto M. Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort. J Atheroscler Thromb 2020 Aug 1.
  • Shioi A, Morioka T, Shoji T, Emoto M. The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification. Nutrients 2020;12:583.
  • Shiratori M, Ozawa T, Miyaoka D, Imanishi Y, Tsuruta D. Panhypopituitarism induced by ipilimumab. Dermatologica Sinica 2020;38:63-64.
  • Suoh M, Fujii H, Nagata Y, Kotani K, Hagihara A, Enomoto M, Tamori A, Inaba M, Kawada N. Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma. Clin J Gastroenterol 2020;13:860-866.
  • Takeuchi Y, Nishida Y, Kondo Y, Imanishi Y, Fukumoto S. Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, multicenter, 52-week, dose-titration phase III study. J Bone Miner Metab 2020;38:687-694.
  • Tsuda A, Ishimura E, Machiba Y, Uedono H, Nakatani S, Mori K, Uchida J, Emoto M. Increased Glomerular Hydrostatic Pressure is Associated with Tubular Creatinine Reabsorption in Healthy Subjects. Kidney Blood Press Res 2020;45:996-1008.
  • Yamada S, Yamamoto S, Fukuma S, Nakano T, Tsuruya K, Inaba M. Geriatric Nutritional Risk Index (GNRI) and Creatinine Index Equally Predict the Risk of Mortality in Hemodialysis Patients: J-DOPPS. Sci Rep 2020;10:5756.
  • Yamazaki Y, Shoji T, Miyashima M, Nagata N, Kakutani Y, Ochi A, Morioka T, Nakatani S, Mori K, Tsujimoto Y, Emoto M. Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort. J Atheroscler Thromb 2020 Dec 23.
  • Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T, Ikewaki K, Inagaki K, Shoji T, Bujo H, Miida T, Yoshida M, Kuzuya M, Yamashita S. Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals. J Atheroscler Thromb 2020;27:409-417.
  • Yoshida S, Kurajoh M, Fukumoto S, Murase T, Nakamura T, Yoshida H, Hirata K, Inaba M, Emoto M. Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry. Sci Rep 2020;10:4437.